{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:40Z","timestamp":1792783000392,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["8227071164"],"award-info":[{"award-number":["8227071164"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10229-5","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:45:24Z","timestamp":1783953924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PIK3CB depletion restores immunosurveillance and enhances radioactive iodine response in hepatocellular carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Yuanren","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengchuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"10229_CR1","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1038\/s41388-020-01444-3","volume":"39","author":"AK Azad","year":"2020","unstructured":"Azad AK, Zhabyeyev P, Vanhaesebroeck B, Eitzen G, Oudit GY, Moore RB, et al. Inactivation of endothelial cell phosphoinositide 3-kinase beta inhibits tumor angiogenesis and tumor growth. Oncogene. 2020;39:6480\u201392. https:\/\/doi.org\/10.1038\/s41388-020-01444-3.","journal-title":"Oncogene"},{"key":"10229_CR2","doi-asserted-by":"publisher","first-page":"D1331","DOI":"10.1093\/nar\/gkaf1250","volume":"54","author":"J Casper","year":"2026","unstructured":"Casper J, et al. The UCSC Genome Browser database: 2026 update. Nucleic Acids Res. 2026;54:D1331\u20135. https:\/\/doi.org\/10.1093\/nar\/gkaf1250.","journal-title":"Nucleic Acids Res"},{"key":"10229_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308. https:\/\/doi.org\/10.3389\/fimmu.2023.1133308.","journal-title":"Front Immunol"},{"key":"10229_CR4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2147\/JHC.S546808","volume":"12","author":"J Ding","year":"2025","unstructured":"Ding J, Zou X, Huang X, Yu L, Hong H, Lin T. ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2025;12:1873\u201392. https:\/\/doi.org\/10.2147\/JHC.S546808.","journal-title":"J Hepatocell Carcinoma"},{"key":"10229_CR5","doi-asserted-by":"publisher","first-page":"1431211","DOI":"10.3389\/fimmu.2024.1431211","volume":"15","author":"G Du","year":"2024","unstructured":"Du G, Dou C, Sun P, Wang S, Liu J, Ma L. Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy. Front Immunol. 2024;15:1431211. https:\/\/doi.org\/10.3389\/fimmu.2024.1431211.","journal-title":"Front Immunol"},{"key":"10229_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41388-023-02931-z","volume":"43","author":"X Gu","year":"2024","unstructured":"Gu X, et al. RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism. Oncogene. 2024;43:624\u201335. https:\/\/doi.org\/10.1038\/s41388-023-02931-z.","journal-title":"Oncogene"},{"key":"10229_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han H, et al. RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett. 2024;604:217191. https:\/\/doi.org\/10.1016\/j.canlet.2024.217191.","journal-title":"Cancer Lett"},{"key":"10229_CR8","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41388-025-03550-6","volume":"44","author":"H Han","year":"2025","unstructured":"Han H, et al. RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Oncogene. 2025;44:3955\u201373. https:\/\/doi.org\/10.1038\/s41388-025-03550-6.","journal-title":"Oncogene"},{"key":"10229_CR9","doi-asserted-by":"publisher","first-page":"e09477","DOI":"10.1002\/advs.202509477","volume":"12","author":"H Han","year":"2025","unstructured":"Han H, et al. ASH2L-K312-Lac Stimulates Angiogenesis in Tumors to Expedite the Malignant Progression of Hepatocellular Carcinoma. Adv Sci (Weinh). 2025;12:e09477. https:\/\/doi.org\/10.1002\/advs.202509477.","journal-title":"Adv Sci (Weinh)"},{"key":"10229_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.775462","volume":"9","author":"X Hao","year":"2021","unstructured":"Hao X, et al. Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges. Front Cell Dev Biol. 2021;9:775462. https:\/\/doi.org\/10.3389\/fcell.2021.775462.","journal-title":"Front Cell Dev Biol"},{"key":"10229_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1186\/s12885-021-08680-0","volume":"21","author":"D Hong","year":"2021","unstructured":"Hong D, Zhou Y, Wan X, Su H, Shao H. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer. 2021;21:1020. https:\/\/doi.org\/10.1186\/s12885-021-08680-0.","journal-title":"BMC Cancer"},{"key":"10229_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/ol.2020.11997","volume":"20","author":"Y Jin","year":"2020","unstructured":"Jin Y, Li R, Zhang Z, Ren J, Song X, Zhang G. ZBED1\/DREF: A transcription factor that regulates cell proliferation. Oncol Lett. 2020;20:137. https:\/\/doi.org\/10.3892\/ol.2020.11997.","journal-title":"Oncol Lett"},{"key":"10229_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.radonc.2011.10.023","volume":"104","author":"C Lin","year":"2012","unstructured":"Lin C, Yu Y, Zhao HG, Yang A, Yan H, Cui Y. Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. Radiother Oncol. 2012;104:395\u2013400. https:\/\/doi.org\/10.1016\/j.radonc.2011.10.023.","journal-title":"Radiother Oncol"},{"key":"10229_CR14","doi-asserted-by":"publisher","first-page":"e1410","DOI":"10.1002\/ctm2.1410","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein-1-H3K4me3-mediated immune escape in oesophageal squamous cell carcinoma. Clin Transl Med. 2023;13:e1410. https:\/\/doi.org\/10.1002\/ctm2.1410.","journal-title":"Clin Transl Med"},{"key":"10229_CR15","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400687R","volume":"38","author":"L Liu","year":"2024","unstructured":"Liu L, et al. PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells. FASEB J. 2024;38:e70024. https:\/\/doi.org\/10.1096\/fj.202400687R.","journal-title":"FASEB J"},{"key":"10229_CR16","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.4103\/0366-6999.191777","volume":"129","author":"Z Lu","year":"2016","unstructured":"Lu Z, et al. Continuous Low-dose-rate Irradiation of Iodine-125 Seeds Inhibiting Perineural Invasion in Pancreatic Cancer. Chin Med J (Engl). 2016;129:2460\u20138. https:\/\/doi.org\/10.4103\/0366-6999.191777.","journal-title":"Chin Med J (Engl)"},{"key":"10229_CR17","doi-asserted-by":"publisher","unstructured":"Mazloumi Gavgani F, Smith Arnesen V, Jacobsen RG, Krakstad C, Hoivik EA, Lewis AE. Class I Phosphoinositide 3-Kinase PIK3CA\/p110alpha and PIK3CB\/p110beta Isoforms in Endometrial Cancer. Int J Mol Sci. 2018; 19 https:\/\/doi.org\/10.3390\/ijms19123931","DOI":"10.3390\/ijms19123931"},{"key":"10229_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41389-022-00378-7","volume":"11","author":"KJ Pridham","year":"2022","unstructured":"Pridham KJ, et al. Connexin 43 confers chemoresistance through activating. P13K Oncogenesis. 2022;11:2. https:\/\/doi.org\/10.1038\/s41389-022-00378-7.","journal-title":"P13K Oncogenesis"},{"key":"10229_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jare.2021.02.002","volume":"33","author":"J Qu","year":"2021","unstructured":"Qu J, et al. PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer. J Adv Res. 2021;33:127\u201340. https:\/\/doi.org\/10.1016\/j.jare.2021.02.002.","journal-title":"J Adv Res"},{"key":"10229_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","volume":"79","author":"L Rimassa","year":"2023","unstructured":"Rimassa L, Finn RS, Sangro B. Combination immunotherapy for hepatocellular carcinoma. J Hepatol. 2023;79:506\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.003.","journal-title":"J Hepatol"},{"key":"10229_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887186","volume":"13","author":"M Sajid","year":"2022","unstructured":"Sajid M, Liu L, Sun C. The dynamic role of NK cells in liver cancers: role in HCC and HBV associated HCC and its therapeutic implications. Front Immunol. 2022;13:887186. https:\/\/doi.org\/10.3389\/fimmu.2022.887186.","journal-title":"Front Immunol"},{"key":"10229_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","volume":"30","author":"K Sankar","year":"2024","unstructured":"Sankar K, et al. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30:1\u201315. https:\/\/doi.org\/10.3350\/cmh.2023.0125.","journal-title":"Clin Mol Hepatol"},{"key":"10229_CR23","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2022;1:e36. https:\/\/doi.org\/10.1002\/imt2.36.","journal-title":"Imeta"},{"key":"10229_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2016.01.017","volume":"373","author":"L Shi","year":"2016","unstructured":"Shi L, et al. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Lett. 2016;373:45\u201356. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.017.","journal-title":"Cancer Lett"},{"key":"10229_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/jcmm.14001","volume":"23","author":"X Shi","year":"2019","unstructured":"Shi X, Zhao Y, Fan C. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3beta complex. J Cell Mol Med. 2019;23:1014\u201321. https:\/\/doi.org\/10.1111\/jcmm.14001.","journal-title":"J Cell Mol Med"},{"key":"10229_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00519-1","volume":"13","author":"Z Shi","year":"2024","unstructured":"Shi Z, Hu C, Zheng X, Sun C, Li Q. Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells. Exp Hematol Oncol. 2024;13:55. https:\/\/doi.org\/10.1186\/s40164-024-00519-1.","journal-title":"Exp Hematol Oncol"},{"key":"10229_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624284","volume":"12","author":"JH Shin","year":"2021","unstructured":"Shin JH, et al. AHR regulates NK cell migration via ASB2-mediated ubiquitination of filamin A. Front Immunol. 2021;12:624284. https:\/\/doi.org\/10.3389\/fimmu.2021.624284.","journal-title":"Front Immunol"},{"key":"10229_CR28","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41401-020-00500-8","volume":"41","author":"P Sun","year":"2020","unstructured":"Sun P, Meng LH. Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity. Acta Pharmacol Sin. 2020;41:1395\u2013402. https:\/\/doi.org\/10.1038\/s41401-020-00500-8.","journal-title":"Acta Pharmacol Sin"},{"key":"10229_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01734-4","volume":"39","author":"J Sun","year":"2020","unstructured":"Sun J, et al. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. J Exp Clin Cancer Res. 2020;39:222. https:\/\/doi.org\/10.1186\/s13046-020-01734-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"10229_CR30","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","journal-title":"Nucleic Acids Res"},{"key":"10229_CR31","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50:D719\u201328. https:\/\/doi.org\/10.1093\/nar\/gkab962.","journal-title":"Nucleic Acids Res"},{"key":"10229_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.717180","volume":"11","author":"S Wei","year":"2021","unstructured":"Wei S, et al. Radioactive iodine-125 in tumor therapy: advances and future directions. Front Oncol. 2021;11:717180. https:\/\/doi.org\/10.3389\/fonc.2021.717180.","journal-title":"Front Oncol"},{"key":"10229_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ph17081031","author":"RC Winter","year":"2024","unstructured":"Winter RC, et al. Future treatment strategies for cancer patients combining targeted alpha therapy with pillars of cancer treatment: external beam radiation therapy, checkpoint inhibition immunotherapy, cytostatic chemotherapy, and brachytherapy. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17081031.","journal-title":"Pharmaceuticals (Basel)"},{"key":"10229_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.21037\/hbsn-22-469","volume":"12","author":"DY Xie","year":"2023","unstructured":"Xie DY, Zhu K, Ren ZG, Zhou J, Fan J, Gao Q. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2023;12:216\u201328. https:\/\/doi.org\/10.21037\/hbsn-22-469.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10229_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3892\/or.10.5.1555","volume":"10","author":"K Xu","year":"2003","unstructured":"Xu K, Wang X, Ling PM, Tsao SW, Wong YC. The alpha1-adrenoceptor antagonist terazosin induces prostate cancer cell death through a p53 and Rb independent pathway. Oncol Rep. 2003;10:1555\u201360. https:\/\/doi.org\/10.3892\/or.10.5.1555.","journal-title":"Oncol Rep"},{"key":"10229_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02093-8","volume":"40","author":"W Xu","year":"2023","unstructured":"Xu W, Chen Y, Zhang Z, Jiang Y, Wang Z. Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma. Med Oncol. 2023;40:221. https:\/\/doi.org\/10.1007\/s12032-023-02093-8.","journal-title":"Med Oncol"},{"key":"10229_CR37","doi-asserted-by":"publisher","first-page":"16258","DOI":"10.3748\/wjg.v20.i43.16258","volume":"20","author":"WD Yu","year":"2014","unstructured":"Yu WD, Peng YF, Pan HD, Wang L, Li K, Gu J. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma. World J Gastroenterol. 2014;20:16258\u201367. https:\/\/doi.org\/10.3748\/wjg.v20.i43.16258.","journal-title":"World J Gastroenterol"},{"key":"10229_CR38","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.7150\/thno.35378","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH(-)). Theranostics. 2019;9:8109\u201326. https:\/\/doi.org\/10.7150\/thno.35378.","journal-title":"Theranostics"},{"key":"10229_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110994","volume":"114","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wei T, Guo D. The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cell Signal. 2024a;114:110994. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110994.","journal-title":"Cell Signal"},{"key":"10229_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45712-2","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression. Nat Commun. 2024b;15:1314. https:\/\/doi.org\/10.1038\/s41467-024-45712-2.","journal-title":"Nat Commun"},{"key":"10229_CR41","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.7150\/ijbs.64003","volume":"17","author":"S Zhao","year":"2021","unstructured":"Zhao S, et al. CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2\/Bax pathway. Int J Biol Sci. 2021;17:3608\u201321. https:\/\/doi.org\/10.7150\/ijbs.64003.","journal-title":"Int J Biol Sci"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10229-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10229-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10229-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:10:54Z","timestamp":1791342654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10229-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10229"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10229-5","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research followed the\n                      Declaration of Helsinki\n                      . The use of human specimens has been approved by the ethics board of Harbin Medical University Affiliated Cancer Hospital (approval number: JS2024-68). Informed consent was gained from the patients. All animal studies and experiments were approved by the Animal Research Committee of Harbin Medical University (approval no. SYDW2023-080) and comply with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"115"}}